Interleukin-1RN gene polymorphisms in elderly patients with rheumatic inflammatory chronic conditions: Association of IL-1RN*2/2 Genotype with polymyalgia rheumatica

Martinez-Taboada, 1994, Conceptos actuales sobre la patogenia de la arteritis de células gigantes, Rev Esp Reumatol, 21, 293

Salvarani, 2002, Polymyalgia rheumatica and giant cell arteritis, N Engl J Med, 347, 261, 10.1056/NEJMra011913

Rodriguez-Valverde, 1997, Risk factors and predictive models of giant cell arteritis in polymyalgia rheumatica, Am J Med, 102, 331, 10.1016/S0002-9343(97)00117-4

Armona, 1995, Arteritis de células gigantes, Med Clin (Barc), 105, 734

Huston, 1978, Temporal arteritis, Ann Intern Med, 88, 162, 10.7326/0003-4819-88-2-162

Emilie, 1994, Production of interleukin 6 by granulomas of giant cell arteritis, Hum Immunol, 39, 17, 10.1016/0198-8859(94)90096-5

Baumann, 1994, The acute phase response, Immunol Today, 15, 74, 10.1016/0167-5699(94)90137-6

Arend, 2000, Biological role of interleukin-1 receptor antagonist isoforms, Ann Rheum Dis, 59, i60, 10.1136/ard.59.suppl_1.i60

Lecron, 1993, High circulating leukaemia inhibitory factor in patients with giant cell arteritis: Independent regulation of LIF and IL-6 under corticosteroid therapy, Clin Exp Immunol, 92, 23, 10.1111/j.1365-2249.1993.tb05942.x

Roche, 1993, Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis, Arthritis Rheum, 36, 1286, 10.1002/art.1780360913

Corrigal, 1997, The sequential analysis of T lymphocyte subsets and interleukin-6 in polymyalgia rheumatica as predictors of disease remission and steroid withdrawal, Br J Rheumatol, 36, 976, 10.1093/rheumatology/36.9.976

Uddhammar, 1998, Cytokines and adhesion molecules in patients with polymyalgia rheumatica, Br J Rheumatol, 37, 766, 10.1093/rheumatology/37.7.766

Straub, 2000, The adrenal steroid status in relation to inflammatory cytokines (interleukin-6 and tumor necrosis factor) in polymyalgia rheumatica, Rheumatology, 39, 624, 10.1093/rheumatology/39.6.624

Cutolo, 2002, Adrenal gland hypofunction in active polymyalgia rheumatica, J Rheumatol, 29, 748

Cutolo, 2006, Serum cytokines and steroidal hormones in polymyalgia rheumatica and elderly-onset rheumatoid arthritis, Ann Rheum Dis, 63, 1438, 10.1136/ard.2006.051979

Hernandez-Rodriguez, 2002, A strong initial systemic inflammatory response is associated with higher corticosteroid requirements and longer duration of therapy in patients with giant-cell arteritis, Arthritis Rheum, 47, 29, 10.1002/art1.10161

Roblot, 1996, Serum cytokine and cytokine receptor levels in patients with giant cell arteritis during corticosteroid therapy, J Rheumatol, 23, 408

Wagner, 1994, Functional profile of tissue infiltrating and ciculating CD68+ cells in giant cell arteritis, J Clin Invest, 94, 1134, 10.1172/JCI117428

Hernandez-Rodriguez, 2003, Elevated production of interleukin 6 is associated with a lower incidence of disease-related ischemic events in patients with giant-cell arteritis, Circulation, 107, 2428, 10.1161/01.CIR.0000066907.83923.32

Weyand, 1994, Tissue cytokine patterns distinguish polymyalgia rheumatica and giant cell arteritis, Ann Intern Med, 121, 484, 10.7326/0003-4819-121-7-199410010-00003

Weyand, 1996, Correlation of the topographical arrangement and the functional pattern of tissue-infiltrating macrophages in giant cell arteritis, J Clin Invest, 98, 1642, 10.1172/JCI118959

Hernandez-Rodriguez, 2004, Tissue production of pro-inflammatory cytokines (IL-1β, TNFα and IL-6) correlates with the intensity of the systemic inflammatory response and with corticosteroid requirements in giant-cell arteritis, Rheumatology, 43, 294, 10.1093/rheumatology/keh058

Weyand, 1997, Disease patterns and tissue cytokine profiles in giant cell arteritis, Arthritis Rheum, 40, 19, 10.1002/art.1780400105

Straub, 1999, Favorable role of interleukin 10 in patients with polymyalgia rheumatica, J Rheumatol, 26, 1318

Pountain, 1998, Circulating levels of IL-1b, IL-6 and soluble IL-2 receptor in polymyalgia rheumatica and giants cell arteritis and rheumatoid arthritis, Br J Rheumatol, 37, 797, 10.1093/rheumatology/37.7.797

Dinarello, 2005, Blocking IL-1 in systemic inflammation, J Exp Med, 201, 1355, 10.1084/jem.20050640

Boiardi, 2000, Interleukin-1 cluster and tumor necrosis factor-a gene polymorphisms in polymyalgia rheumatica, Clin Exp Rheumatol, 18, 675

Gonzalez-Gay, 2000, Lack of association between IL-1 cluster and TNF-alpha gene polymorphisms in giant cell arteritis, Clin Exp Rheumatol, 18, 431

Hacker, 2001, Influence of the IL-1Ra gene polymorphism on in vivo synthesis of IL-1Ra and IL-1β after live yellow fever vaccination, Clin Exp Immunol, 125, 465, 10.1046/j.1365-2249.2001.01621.x

Danis, 1995, Cytokine production by normal human monocytes: Inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism, Clin Exp Immunol, 99, 303, 10.1111/j.1365-2249.1995.tb05549.x

Hunder, 1990, The American College of Rheumatology 1990 criteria for the Classification of giant cell arteritis, Arthritis Rheum, 33, 1122, 10.1002/art.1780330810

Martínez-Taboada, 1996, The inflammatory infiltrate in giant cell arteritis selects against B lymphocytes, J Rheumatol, 23, 1011

Chuang, 1982, Polymyalgia rheumatica: A 10- year epidemiologic and clinical study, Ann Intern Med, 97, 672, 10.7326/0003-4819-97-5-672

González-Gay, 1997, Polymyalgia rheumatica without significantly increased ESR: A more benign syndrome, Arch Intern Med, 157, 317, 10.1001/archinte.157.3.317

Arnett, 1988, The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis, Arthritis Rheum, 31, 315, 10.1002/art.1780310302

Brack, 1999, Disease pattern in cranial and large-vessel giant cell arteritis, Arthritis Rheum, 42, 311, 10.1002/1529-0131(199902)42:2<311::AID-ANR14>3.0.CO;2-F

Tarlow, 1993, Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat, Hum Genet, 91, 403, 10.1007/BF00217368

Martínez-Taboada, 2004, HLA-DRB1 allele distribution in polymyalgia rheumatica and giant cell arteritis: Influence on clinical subgroups and prognosis, Semin Arthritis Rheum, 34, 454, 10.1016/j.semarthrit.2003.12.001

Martínez-Taboada, 2000, Arteritis de células gigantes, Seminarios de Reumatología, 1, 141

Cantini, 2005, Inflammatory changes of hip synovial structures in polymyalgia rheumatica, Clin Exp Rheumatol, 23, 462

Cantini, 2001, Shoulder ultrasonography in the diagnosis of polymyalgia rheumatica: A case-control study, J Rheumatol, 28, 1049

Warle, 2003, Are cytokine polymorphisms related to in vitro cytokine production profiles?, Liver Transpl, 9, 170, 10.1053/jlts.2002.50014

Hurme, 1998, IL-1 receptor antagonist (IL-1Ra) plasma levels are coordinately regulated by both IL-1RA and IL-1 beta genes, Eur J Immunol, 28, 2598, 10.1002/(SICI)1521-4141(199808)28:08<2598::AID-IMMU2598>3.0.CO;2-K

Santtila, 1998, Presence of IL-1RA allele 2 (IL-1RN*2) is associated with enhanced IL-1 beta production in vitro, Scand J Immunol, 47, 195, 10.1046/j.1365-3083.1998.00300.x

Lopez-Hoyos, 2004, Clinical utility of anti-CCP antibodies in the differential diagnosis of elderly-onset rheumatoid arthritis and polymyalgia rheumatica, Rheumatology, 43, 655, 10.1093/rheumatology/keh143